Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A patient intake form on a desk in a clinical setting

Jul 27, 2026

Reciprocal Clinical Trials

Massive Bio and Sequence Me Now have joined forces to enhance patient access to oncology clinical trials through a new partnership.This collaboration utilizes Massive Bio's AI-driven trial-matching platform to assist patients who have received genomic sequencing results in finding relevant clinical studies based on their specific cancer types and biomarkers. Sequence Me Now will feature Massive Bio on its "Find a Trial" page, while Massive Bio will create a dedicated landing page for Sequence Me
Minimalist representation of growth and partnership in biopharmaceuticals

Jul 27, 2026

Harbour BioMed Forecasts Record H1 2026 Profit as Strategic Partnerships Drive Growth

Harbour BioMed is anticipating significant growth in the first half of 2026, driven by strategic partnerships and advancements in AI-driven drug discovery.The biopharmaceutical company expects revenues to reach between $120 million and $125 million, marking a 19% to 24% increase compared to the same period in 2025. This anticipated growth is coupled with projected profits ranging from $62 million to $67 million, reinforcing Harbour BioMed's position in the market after achieving seven consecutiv
A flat illustration of a drug compound in a minimalist style.

Jul 27, 2026

Chinese biotech is stealing the emerging market trade that AI dominated for two years

Recent trends indicate a significant shift in investment focus from AI-driven stocks to Chinese biotech firms, reflecting changing perceptions of market valuations.In the first quarter of 2025, Chinese companies surged to represent 32% of global biotech licensing deal value, a notable increase from 21% in the previous two years. This shift is largely attributed to Western pharmaceutical companies seeking new pipelines amid patent expirations. Major players like Jiangsu Hengrui and BeiGene have d
A speech bubble and hand symbolizing patient voices in healthcare.

Jul 26, 2026

New AI platform aims to give patients a strong voice in medicines funding

Boehringer Ingelheim has introduced an innovative AI platform called 'Patient Input Buddy' to enhance patient engagement in the evaluation of medicines funding.This new tool aims to simplify the process for patients to contribute their perspectives to the Pharmaceutical Benefits Advisory Committee (PBAC). By collaborating with various patient organizations, Boehringer Ingelheim seeks to ensure that patient voices are more effectively integrated into decision-making processes regarding pharmaceut